Early risk of cardiovascular events after commencing hormone replacement therapy
- 1 August 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Current Opinion in Lipidology
- Vol. 12 (4) , 371-375
- https://doi.org/10.1097/00041433-200108000-00001
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Genetic Susceptibility to Venous ThrombosisNew England Journal of Medicine, 2001
- Effect of Oral Postmenopausal Hormone Replacement on Progression of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisNew England Journal of Medicine, 2000
- Early Risks of Hormone Therapy in Patients With Coronary Heart DiseasePublished by American Medical Association (AMA) ,2000
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONSAnnual Review of Public Health, 1998
- Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Blood Coagulation and Fibrinolysis in Postmenopausal WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutationThe Lancet, 1994
- Enhanced Expression of Vascular Matrix Metalloproteinases Induced In Vitro by Cytokines and in Regions of Human Atherosclerotic LesionsaAnnals of the New York Academy of Sciences, 1994